Manning & Napier Advisors LLC Astrazeneca PLC Transaction History
Manning & Napier Advisors LLC
- $7.84 Trillion
- Q3 2025
A detailed history of Manning & Napier Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Manning & Napier Advisors LLC holds 1,762,193 shares of AZN stock, worth $145 Million. This represents 1.72% of its overall portfolio holdings.
Number of Shares
1,762,193
Previous 2,152,535
18.13%
Holding current value
$145 Million
Previous $150 Billion
10.12%
% of portfolio
1.72%
Previous 1.79%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,449Shares Held
489MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.28 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.39 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.83 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.59 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.57 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $255B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...